FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:425-426 July 27, 2006 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Ethics and the Pharmaceutical Industry
Edited by Michael A. Santoro and Thomas M. Gorrie. 492 pp. New York, Cambridge University Press, 2005. $40. ISBN 0-521-85496-2.

The Law and Ethics of the Pharmaceutical Industry
By M.N. Graham Dukes. 409 pp. Amsterdam, Elsevier, 2006. $129.95. ISBN 0-444-51868-1.

Hardly a day passes without the appearance of headlines related to the pharmaceutical industry. Whether such stories herald successes (such as advances in drug therapy) or probe unsavory issues (such as problems in drug development, pricing, or availability), considerable attention is focused on the industry. Such attention isn't terribly surprising, given the high medical, monetary, and moral stakes involved. There are obvious medical needs for new and better pharmaceutical products, yet the development of these products can take, and make, substantial amounts of money.

Although few observers would argue against fair profits for the creation . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.